$0.00
$0.00
SR9009 is a quite powerful SARM (Selective Androgen Receptor Modulator) that has been proven to bring about incredible improvements in endurance and fat loss.
Original price was: $99.99.$89.99Current price is: $89.99.
In stock
Stenabolic, or SR-9009, is a research compound developed to target Rev-ErbA receptors, which regulate the body’s circadian rhythm, metabolism, and fat storage. Although commonly grouped with SARMs, Stenabolic is not a true SARM—it does not bind to androgen receptors. Instead, it enhances mitochondrial activity and fat oxidation at the cellular level.
Originally studied for its potential to treat metabolic and cardiovascular conditions, SR-9009 has since gained attention in performance-focused research for its role in increasing endurance and promoting fat loss—without muscle loss or hormonal disruption.
| Chemical Name | Stenabolic (SR-9009) |
| CAS Number | 1379686-30-2 |
| Molecular Formula | C20H24ClN3O4S |
| Molecular Weight | 437.94 g/mol |
| IUPAC Name | [(3,5-dimethyl-4-((4-(trifluoromethyl)phenyl)amino)phenyl)methyl]-2-methyl-4-(trifluoromethyl)phenol |
Stenabolic works by activating Rev-ErbA receptors, which control the expression of genes involved in fat storage, inflammation, and circadian behavior. When activated, these receptors may enhance the body’s metabolic rate, increase the number of mitochondria in muscle cells, and reduce the activity of fat-storing enzymes.
This makes SR-9009 a unique compound in research studies aiming to simulate the benefits of exercise—such as increased endurance and fat loss—without the same hormonal impact as SARMs or anabolic steroids.
Animal studies show SR-9009 can improve metabolic function, increase endurance, and reduce body fat without impacting muscle tissue or altering hormone levels. Mice treated with SR-9009 ran 50% longer and burned more fat than untreated controls. While human data is limited, these findings continue to drive performance and metabolic research.
SR-9009 is commonly dosed between 20–30mg per day in research studies. Due to its short half-life (~4 hours), split dosing 2–3 times daily is recommended for consistent serum levels. Most research cycles last 8–12 weeks.
Unlike most SARMs, SR-9009 does not require post-cycle therapy (PCT), as it does not interact with the body’s hormone system.
SR-9009 is often stacked to enhance fat loss and endurance during cutting phases or bridging cycles. Its non-suppressive profile makes it an ideal addition to hormone-based stacks or standalone research.
Popular stacks include:
Yes. SR-9009 is legal to purchase and possess for research purposes in Canada. It is not FDA-approved for human consumption.
No. SR-9009 is non-hormonal and does not impact testosterone production, making it PCT-free in most protocols.
SR-9009 has a short half-life of approximately 4 hours. For optimal results, split dosing is recommended throughout the day.
This product is available in powder and liquid form with ≥98% purity, suitable for validated laboratory research applications.
For laboratory use only. Not for human or veterinary use.
This material is intended strictly for research purposes under controlled laboratory conditions. It is the buyer’s responsibility to ensure legal and ethical use in accordance with institutional, local, and federal guidelines.
Always wear proper safety equipment and follow appropriate handling procedures.
Helixx Online is excited to announce that our premium SARMs are officially back in stock and ready to ship starting October 24th!
Don’t miss your chance to restock your cycle — quantities are limited and demand is high.
Order now to secure your products!
